Category:Dan Burton: Difference between revisions

From UmbraXenu
Jump to navigation Jump to search
No edit summary
No edit summary
 
(9 intermediate revisions by 2 users not shown)
Line 2: Line 2:
|birthname = Danny Lee Burton
|birthname = Danny Lee Burton
|image = Dan Burton, Official Portrait, 108th Congress.jpg
|image = Dan Burton, Official Portrait, 108th Congress.jpg
|image_size = 200px
|birth_date = {{birth date and age|1938|06|21}}
|birth_date = {{birth date and age|1938|06|21}}
|birth_place = [[Wikipedia:Indianapolis, Indiana|Indianapolis, Indiana]]
|birth_place = [[Wikipedia:Indianapolis, Indiana|Indianapolis, Indiana]]
Line 38: Line 39:
| leader_name4 =
| leader_name4 =
}}
}}
'''Danny Lee Burton''' (born June 21, 1938) is an [[Wikipedia:United States|American]] politician. Burton is the former [[Wikipedia:United States House of Representatives|U.S. Representative]] for Indiana's 5th congressional district, and previously the 6th district, serving from 1983 until 2013. He is a member of the [[Wikipedia:Republican Party (United States)|Republican Party]] and the [[Wikipedia:Tea Party Caucus|Tea Party Caucus]].<ref>http://politicalticker.blogs.cnn.com/2011/07/29/who-is-the-tea-party-caucus-in-the-house/</ref>
{{Infobox Organization
| name = John T. Doolittle, LLC
| abbreviation =
| image =
| size = 250px
| caption =
| type =
| status =
| tax_id =
| registration_id = S3634203
| jurisdiction = us-va
| formation = {{start_date|2011|5|5}}
| headquarters =
| coords =
| purpose =
| leader_title = President
| leader_name =
| leader_title2 = Treasurer
| leader_name2 =
| leader_title3 = Secretary
| leader_name3 =
| leader_title4 = Agent
| leader_name4 =
}}
==Lobbyist activity==
==Lobbyist activity==
===CCHR===
===CCHR===
Line 83: Line 61:
|
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
|- style="vertical-align: top; background:#F5F4F2"
|2015 3rd Quarter
|style="text-align:right;"|$30000
|[[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852224 300852224]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act and it its Senate counterpart (not yet introduced).
|- style="vertical-align: top; background:#F5F4F2"
|- style="vertical-align: top; background:#F5F4F2"
|2015 4th Quarter
|2015 4th Quarter
Line 103: Line 71:
|
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
|- style="vertical-align: top; background:#F5F4F2"
|2015 4th Quarter
|style="text-align:right;"|$30000
|[[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852220 300852220]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act and it its Senate counterpart (not yet introduced).
|- style="vertical-align: top; background:#F5F4F2"
|- style="vertical-align: top; background:#F5F4F2"
|2016 1st Quarter
|2016 1st Quarter
Line 129: Line 87:
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
|- style="vertical-align: top; background:#F5F4F2"
|- style="vertical-align: top; background:#F5F4F2"
|2016 1st Quarter
|2016 2nd Quarter
|style="text-align:right;"|$20000
|style="text-align:right;"|$20000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300815526 300815526]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300815294 300815294]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|[[:Category:Dan Burton|Dan Burton]]
|
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in H. R. 2646 - Helping Families in Mental Health Crisis and in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015.
*[[:Category:2017|2017]] House Appropriations Bill on Agriculture, Rural Development on [[:Category:FDA|FDA]] funding
*
*[[:Category:2016|2016]], [[:Category:Helping Families in Mental Health Crisis Act of 2016]]
*Opposition to FDA Proposed Rule on electroconvulsive therapy (ECT) devices.
*[[:Category:2015|2015]], [[:Category:2016|2016]], [[:Category:Advancing Breakthrough Devices for Patients Act|Advancing Breakthrough Devices for Patients Act]]
*[[:Category:2016|2016]], [[:Category:Mental Health Reform Act of 2016|Mental Health Reform Act of 2016]]
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
|- style="vertical-align: top; background:#F5F4F2"
|- style="vertical-align: top; background:#F5F4F2"
|2016 1st Quarter
|2016 3rd Quarter
|style="text-align:right;"|$30000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852217 300852217]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in H. R. 2646 - Helping Families in Mental Health Crisis and in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015.
*
*Opposition to FDA Proposed Rule on electroconvulsive therapy (ECT) devices.
|- style="vertical-align: top; background:#F5F4F2"
|2016 2nd Quarter
|style="text-align:right;"|$20000
|style="text-align:right;"|$20000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300815294 300815294]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300830023 300830023]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:CCHR|CCHR]]
Line 168: Line 117:
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
|- style="vertical-align: top; background:#F5F4F2"
|- style="vertical-align: top; background:#F5F4F2"
|2016 2nd Quarter
|2016 4th Quarter
|style="text-align:right;"|$30000
|style="text-align:right;"|$30000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852213 300852213]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852195 300852195]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in House Appropriations Subcommittee Bill on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for FY 2017 (containing provisions of H. R. 6), in H. R. 2646 - Helping Families in Mental Health Crisis in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015, in S. 2680 - Mental Health Reform Act of 2016 and in FDA Proposed Rule on Electroconvulsive Therapy (ECT).
|- style="vertical-align: top; background:#F5F4F2"
|2016 3rd Quarter
|style="text-align:right;"|$20000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300830023 300830023]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:CCHR|CCHR]]
Line 193: Line 132:
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
*[[:Category:2014|2014]], [[:Category:FDA|FDA]] [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy]] classification under [[:Category: FDA Proposed Rule Change on Electroconvulsive Therapy (ECT)|ECT Proposed Rule Change]]
|- style="vertical-align: top; background:#F5F4F2"
|- style="vertical-align: top; background:#F5F4F2"
|2016 3rd Quarter
|2017 1st Quarter
|style="text-align:right;"|$30000
|style="text-align:right;"|$30000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]], [[:Category:US Department of Health and Human Services|US Department of Health and Human Services]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852210 300852210]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300865947 300865947]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:CCHR|CCHR]]
|[[:Category:Dan Burton|Dan Burton]]
|[[:Category:Dan Burton|Dan Burton]]
|
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
*Seeking to maintain or increase protection for the public with reference to psychiatric treatments including drugs and brain devices in H. R. 6 - 21st Century Cures Act, in House Appropriations Subcommittee Bill on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for FY 2017 (containing provisions of H. R. 6), in H. R. 2646 - Helping Families in Mental Health Crisis in S. 1077 - Advancing Breakthrough Devices For Patients Act of 2015, in S. 2680 - Mental Health Reform Act of 2016 and in FDA Proposed Rule on Electroconvulsive Therapy (ECT).
|- style="vertical-align: top; background:#F5F4F2"
|- style="vertical-align: top; background:#F5F4F2"
|2016 4th Quarter
|2017 2nd Quarter
|style="text-align:right;"|$30000
|style="text-align:right;"|$30000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]]
|[[:Category:US Senate|US Senate]], [[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Department of Health and Human Services|US Department of Health and Human Services]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300852195 300852195]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300897769 300897769]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:CCHR|CCHR]]
|
|[[:Category:Dan Burton|Dan Burton]]
|
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
|- style="vertical-align: top; background:#F5F4F2"
|- style="vertical-align: top; background:#F5F4F2"
|2017 1st Quarter
|2017 3rd Quarter
|style="text-align:right;"|$30000
|style="text-align:right;"|$30000
|[[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Senate|US Senate]], [[:Category:US Department of Health and Human Services|US Department of Health and Human Services]]
|[[:Category:US Senate|US Senate]], [[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Department of Health and Human Services|US Department of Health and Human Services]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300865947 300865947]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300910265 300910265]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|[[:Category:CCHR|CCHR]]
|
|[[:Category:Dan Burton|Dan Burton]]
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]], [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy (ECT)]]
|- style="vertical-align: top; background:#F5F4F2"
|2017 4th Quarter
|style="text-align:right;"|$30000
|[[:Category:US Senate|US Senate]], [[:Category:US House of Representatives|US House of Representatives]], [[:Category:US Department of Health and Human Services|US Department of Health and Human Services]]
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300937075 300937075]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|[[:Category:CCHR|CCHR]]
|
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]], [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy (ECT)]]
|}
===Dan Burton===
{| class="wikitable" style="font-size: 90%;"
!style="background: #D3C6A4;" |Year/Period
!style="padding: 5px; background: #D3C6A4;" |Income
!style="padding: 5px; background: #D3C6A4;" |Agencies lobbied
!style="padding: 5px; background: #D3C6A4;" |Doc ID
!style="padding: 5px; background: #D3C6A4;" |Firm
!style="padding: 5px; background: #D3C6A4;" |Client
!style="padding: 5px; background: #D3C6A4;" |Lobbyist
!style="padding: 5px; background: #D3C6A4;" |Issues
|- style="vertical-align: top; background:#F5F4F2"
|2017 1st Quarter
|style="text-align:right;"|$20000
|
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300880563 300880563]
|[[:Category:John T. Doolittle|John T. Doolittle, LLC]]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|
|
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
|- style="vertical-align: top; background:#F5F4F2"
|2017 2nd Quarter
|style="text-align:right;"|$20000
|
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300897747 300897747]
|[[:Category:John T. Doolittle|John T. Doolittle, LLC]]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]]
|- style="vertical-align: top; background:#F5F4F2"
|2017 3rd Quarter
|style="text-align:right;"|$20000
|
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300909741 300909741]
|[[:Category:John T. Doolittle|John T. Doolittle, LLC]]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]], [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy (ECT)]]
|- style="vertical-align: top; background:#F5F4F2"
|2017 4th Quarter
|style="text-align:right;"|$20000
|
|[http://disclosures.house.gov/ld/pdfform.aspx?id=300936821 300936821]
|[[:Category:John T. Doolittle|John T. Doolittle, LLC]]
|[[:Category:Dan Burton|Dan Burton International LLC]]
|
|
*[[:Category:2015|2015]] [[:Category:Psychiatric treatment|Psychiatric treatment]] in [[:Category:21st Century Cures Act|21st Century Cures Act]], [[:Category:Electroconvulsive Therapy (ECT)|Electroconvulsive Therapy (ECT)]]
|}
|}
<!-- End lobbyist tables -->
<!-- End lobbyist tables -->
Line 227: Line 227:
==See also==
==See also==
*{{Wikipedia-inline|Dan Burton}}
*{{Wikipedia-inline|Dan Burton}}

==Notes==
{{Reflist}}


==External links==
==External links==
*[https://www.opensecrets.org/lobby/firmsum.php?id=F47953&year=2016 Lobbying Spending Database-Dan Burton International, 2016], OpenSecrets.
*[https://www.opensecrets.org/lobby/firmsum.php?id=F47953 Lobbying Spending Database-Dan Burton International], OpenSecrets.
*[https://www.opensecrets.org/lobby/clientsum.php?id=F47953&year=2016 Lobbying Spending Database - Dan Burton International, 2016], OpenSecrets.
*[https://www.opensecrets.org/lobby/clientsum.php?id=F47953 Lobbying Spending Database - Dan Burton International], client, OpenSecrets.
*[https://www.opensecrets.org/revolving/rev_summary.php?id=77750 Revolving Door: Dan Burton Employment Summary], OpenSecrets.
*[https://www.opensecrets.org/revolving/rev_summary.php?id=77750 Revolving Door: Dan Burton Employment Summary], OpenSecrets.
*[http://scienceblogs.com/insolence/2012/04/26/dan-burtons-last-antivaccine-hurrah/ Dan Burton's last antivaccine hurrah?], ScienceBlogs.
*[http://scienceblogs.com/insolence/2012/04/26/dan-burtons-last-antivaccine-hurrah/ Dan Burton's last antivaccine hurrah?], ScienceBlogs.


{{DEFAULTSORT: Burton, Dan}}
{{DEFAULTSORT: Burton, Dan}}
[[Category:Anti-vax]]
[[Category:Anti-vaxx]]
[[Category:House Oversight and Government Reform Committee]]
[[Category:House Oversight and Government Reform Committee]]
[[Category:Lobbyist]]
[[Category:Lobbyist]]

Latest revision as of 03:12, 12 June 2019

Dan Burton
Born Danny Lee Burton
(1938-06-21) June 21, 1938 (age 86)
Indianapolis, Indiana
Residence Indianapolis, Indiana
Alma mater Cincinnati Christian University
Occupation Lobbyist
Political party Republican
Religion Christian churches and churches of Christ
Spouse(s)
  • Barbara J. Logan Burton (?-2002)
  • Samia Tawil (2006-Present)
Dan Burton International, LLC
Formation January 22, 2013 (2013-01-22)
Jurisdiction us-in
Registration no. 2013012400212
Headquarters 12141 E 79th ST, Indianapolis, IN, 46236, USA

Danny Lee Burton (born June 21, 1938) is an American politician. Burton is the former U.S. Representative for Indiana's 5th congressional district, and previously the 6th district, serving from 1983 until 2013. He is a member of the Republican Party and the Tea Party Caucus.[1]

Lobbyist activity

CCHR

Year/Period Income Agencies lobbied Doc ID Firm Client Lobbyist Issues
2015 3rd Quarter $20000 US Senate 300755227 Dan Burton International LLC CCHR Dan Burton
2015 4th Quarter $20000 US Senate 300783931 Dan Burton International LLC CCHR Dan Burton
2016 1st Quarter $20000 US House of Representatives, US Senate 300796968 Dan Burton International LLC CCHR Dan Burton
2016 2nd Quarter $20000 US House of Representatives, US Senate 300815294 Dan Burton International LLC CCHR Dan Burton
2016 3rd Quarter $20000 US House of Representatives, US Senate 300830023 Dan Burton International LLC CCHR Dan Burton
2016 4th Quarter $30000 US House of Representatives, US Senate 300852195 Dan Burton International LLC CCHR Dan Burton
2017 1st Quarter $30000 US House of Representatives, US Senate, US Department of Health and Human Services 300865947 Dan Burton International LLC CCHR Dan Burton
2017 2nd Quarter $30000 US Senate, US House of Representatives, US Department of Health and Human Services 300897769 Dan Burton International LLC CCHR
2017 3rd Quarter $30000 US Senate, US House of Representatives, US Department of Health and Human Services 300910265 Dan Burton International LLC CCHR
2017 4th Quarter $30000 US Senate, US House of Representatives, US Department of Health and Human Services 300937075 Dan Burton International LLC CCHR

Dan Burton

Year/Period Income Agencies lobbied Doc ID Firm Client Lobbyist Issues
2017 1st Quarter $20000 300880563 John T. Doolittle, LLC Dan Burton International LLC
2017 2nd Quarter $20000 300897747 John T. Doolittle, LLC Dan Burton International LLC
2017 3rd Quarter $20000 300909741 John T. Doolittle, LLC Dan Burton International LLC
2017 4th Quarter $20000 300936821 John T. Doolittle, LLC Dan Burton International LLC

See also

Notes

  1. ↑ http://politicalticker.blogs.cnn.com/2011/07/29/who-is-the-tea-party-caucus-in-the-house/

External links

Subcategories

This category has the following 4 subcategories, out of 4 total.

2

B

F

J

Media in category "Dan Burton"

The following 2 files are in this category, out of 2 total.

Retrieved from "http://192.168.1.3/mediawiki/index.php?title=Category:Dan_Burton&oldid=126768"